I had expected the first visit to take several days, but I thought after that it was more like one or two days involved. Thanks for your reply. I will contact them for more details.
I suppose there are so few patients that have taken part in the study. I was wondering what someone who had been in the trial would have to say about side effects, etc. When reading the articles that have been released, it appears there are minor toxicities, and that induced
HER2/neu immunity seems to reduce the recurrence rate in patients with node positive breast cancer.
In order to be in the trial you have to know if you are HLA2+ or not, so I plan to find that out and go from there.
Thanks, Laurie
Barbara